Metformin synergistically enhances the antitumor activity of the third‐generation EGFR‐TKI CO‐1686 in lung cancer cells through suppressing NF‐κB signaling.
Saved in:
| Title: | Metformin synergistically enhances the antitumor activity of the third‐generation EGFR‐TKI CO‐1686 in lung cancer cells through suppressing NF‐κB signaling. |
|---|---|
| Authors: | Pan, Yong‐Hong1, Lin, Cai‐Yu1, Lu, Cong‐Hua1, Li, Li1, Wang, Yu‐Bo1, Chen, Heng‐Yi1, He, Yong1 |
| Source: | Clinical Respiratory Journal. Dec2018, Vol. 12 Issue 12, p2642-2652. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17526981 |
|---|---|
| DOI: | 10.1111/crj.12970 |
